Schedule 13G: Lincoln Holds 365,849 Shares of SSKN

Rhea-AI Filing Summary

Lincoln Alternative Strategies LLC reported beneficial ownership of 365,849 shares of Strata Skin Sciences, Inc. common stock, representing 6.94% of the outstanding shares based on 5,268,708 shares outstanding as of September 3, 2025. The filing is a Schedule 13G indicating passive ownership under the Exchange Act rules and expressly certifies the shares were not acquired to change or influence control of the issuer. The reporting entity is organized in Delaware and lists its principal business address in Miami Beach, FL. The filing was signed by Stephen Temes as Managing Member on September 4, 2025.

Positive

• Material disclosure of a >5% position provides transparency to the market
• Filed as Schedule 13G, indicating passive ownership and no current intent to change control
• Exact ownership and percent are stated: 365,849 shares and 6.94% based on 5,268,708 shares outstanding

Negative

• None.

Insights

Securities Analyst

TL;DR: A passive investor disclosed a material >5% stake in SSKN, signaling notable share ownership without intent to influence control.

The Schedule 13G shows Lincoln Alternative Strategies LLC holds 365,849 shares or 6.94% of Strata Skin Sciences, which meets the reporting threshold for significant ownership but is filed under the passive ownership regime. That classification limits implications for corporate control but establishes Lincoln as a sizeable holder whose trading could affect float and liquidity. The filing includes standard certifications that the position is not intended to change control, which reduces immediate governance risk but does not preclude future changes in intent that would require an amended filing.

Corporate Governance Expert

TL;DR: Material disclosure of a >5% holder is governance-relevant but currently shows no activist intent.

The disclosure is procedurally important: it informs shareholders and the company of a significant investor. Because the filer used Schedule 13G and certified no intent to influence control, this is consistent with a passive investment approach. From a governance perspective, continued monitoring is warranted because any shift from passive to active intent would trigger different filing requirements and potentially greater board engagement.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

STRATA Skin Sciences, Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

86272A305

(CUSIP Number)

09/03/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 86272A305

1

Names of Reporting Persons

Lincoln Alternative Strategies LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 365,849.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 365,849.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

365,849.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Beneficial ownership percentage is based on 5,268,708 shares of the Issuer's common stock issued and outstanding as of September 3, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: STRATA Skin Sciences, Inc.
(b)	Address of issuer's principal executive offices: 5 Walnut Grove Drive, Suite 140, Horsham, PENNSYLVANIA, 19044.
Item 2.
(a)	Name of person filing: Lincoln Alternative Strategies LLC
(b)	Address or principal business office or, if none, residence: 404 Washington Ave., Suite 650, Miami Beach, FL 33139
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock, $0.001 par value
(e)	CUSIP No.: 86272A305
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 365,849
(b)	Percent of class: 6.94%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 365,849
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 365,849
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lincoln Alternative Strategies LLC

Signature:	/s/ Stephen Temes
Name/Title:	Stephen Temes/Managing Member
Date:	09/04/2025

FAQ

How many SSKN shares does Lincoln Alternative Strategies LLC own?

The filer reports ownership of 365,849 shares of Strata Skin Sciences common stock.

What percent of SSKN does Lincoln Alternative Strategies LLC own?

The filing states the position represents 6.94% of the outstanding common stock based on 5,268,708 shares outstanding as of September 3, 2025.

Is this Schedule 13G filed as passive or active ownership?

It is filed on Schedule 13G and the filer certifies the securities are not held to change or influence control, indicating passive ownership.

Who signed the Schedule 13G for Lincoln Alternative Strategies LLC?

The document is signed by /s/ Stephen Temes, Managing Member, dated September 4, 2025.

Where is Lincoln Alternative Strategies LLC organized and located?

The filer is organized in Delaware with a principal business address at 404 Washington Ave., Suite 650, Miami Beach, FL 33139.